PTEN and neoplasm: To confirm that Pten deficiency is responsible for p110 isoform switch, we next investigated whether p110α-deficient tumor cells with PTEN-haploinsufficiency remained sensitive to p110β inhibition by treating them with a p110β-specific inhibitor (TGX221) [38].